arrow
H

Hilary W. Heuer

University of California San Francisco
H指数:39
被引数:5,599

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal functional network connectivity changes across the clinical stages of C9orf72 hexanucleotide repeat expansion carriers
2026-09-010
OA
Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling
2026-01-290
OAAI
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differences

遗传性额颞叶痴呆突变通过全颅内体积差异揭示的神经发育效应

2025-11-190
OA
Design considerations for C9orf72 disease prevention trials

C9orf72疾病预防试验的设计考虑

BRAIN
IF11.7
2025-10-010
OAAI
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers

GRN致病性变异携带者中功能连接与疾病进展标志物的关联

2025-09-160
OAAI
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

作者更正: 脑脊液蛋白质组的大规模网络分析确定了额颞叶变性的分子特征

2025-07-070
OAAI
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia

行为变异型额颞叶痴呆临床表型的性别差异

2025-04-251
OAAI
Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia

常染色体显性遗传性额颞叶痴呆临床表现的性别差异

2025-04-250
OA
Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia

常染色体显性遗传性额颞叶痴呆在执行功能和行为储备方面的性别差异

2025-04-250
OAAI
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing

通过全基因组测序破译ftld-tdp病理亚型的不同遗传危险因素

2025-04-250
OA
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders

全面的血浆胶质纤维酸性蛋白和神经丝蛋白轻链在额颞叶痴呆谱系障碍中的横断面和纵向比较

2025-03-120
OA
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials

TabCAT-EXAMINER的开发与验证:一种基于平板电脑的用于研究和临床试验的执行功能测试组合

2025-03-010
PRE
Clinical and neuropathological associations of plasma Aβ42/Aβ40, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
2025-01-290
OA
Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative disease
2025-01-151
OAAI
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia
2024-12-230
OA
Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration
2024-10-220
PRE
Better cardiovascular health is associated with slowed clinical progression in autosomal dominant frontotemporal lobar degeneration variant carriers
2024-09-060
OA
CSF Proteomics in Patients With Progressive Supranuclear Palsy
2024-08-130
PRE